Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates.

Martin MV, Mirnics K, Nisenbaum LK, Vawter MP.

Mol Neuropsychiatry. 2015 Jul;1(2):82-93.

2.

Neurogranin alters the structure and calcium binding properties of calmodulin.

Hoffman L, Chandrasekar A, Wang X, Putkey JA, Waxham MN.

J Biol Chem. 2014 May 23;289(21):14644-55. doi: 10.1074/jbc.M114.560656. Epub 2014 Apr 8.

3.

Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia.

Thong JY, Qiu A, Sum MY, Kuswanto CN, Tuan TA, Donohoe G, Sitoh YY, Sim K.

PLoS One. 2013 Dec 30;8(12):e85603. doi: 10.1371/journal.pone.0085603. eCollection 2013.

4.

The impact of genome-wide supported schizophrenia risk variants in the neurogranin gene on brain structure and function.

Walton E, Geisler D, Hass J, Liu J, Turner J, Yendiki A, Smolka MN, Ho BC, Manoach DS, Gollub RL, Roessner V, Calhoun VD, Ehrlich S.

PLoS One. 2013 Oct 2;8(10):e76815. doi: 10.1371/journal.pone.0076815. eCollection 2013.

5.

Early postnatal lesion of the medial dorsal nucleus leads to loss of dendrites and spines in adult prefrontal cortex.

Marmolejo N, Paez J, Levitt JB, Jones LB.

Dev Neurosci. 2012;34(6):463-76. doi: 10.1159/000343911. Epub 2013 Feb 12.

6.

Neurogranin targets calmodulin and lowers the threshold for the induction of long-term potentiation.

Zhong L, Gerges NZ.

PLoS One. 2012;7(7):e41275. doi: 10.1371/journal.pone.0041275. Epub 2012 Jul 25.

7.

Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Ohi K, Hashimoto R, Yasuda Y, Nemoto K, Ohnishi T, Fukumoto M, Yamamori H, Umeda-Yano S, Okada T, Iwase M, Kazui H, Takeda M.

PLoS One. 2012;7(1):e29780. doi: 10.1371/journal.pone.0029780. Epub 2012 Jan 12.

8.

The effect of neurogranin on neural correlates of episodic memory encoding and retrieval.

Krug A, Krach S, Jansen A, Nieratschker V, Witt SH, Shah NJ, Nöthen MM, Rietschel M, Kircher T.

Schizophr Bull. 2013 Jan;39(1):141-50. doi: 10.1093/schbul/sbr076. Epub 2011 Jul 28.

9.

Similar intracellular peptide profile of TAP1/β2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis.

Castro LM, Berti DA, Russo LC, Coelho V, Gozzo FC, Oliveira V, Ferro ES.

AAPS J. 2010 Dec;12(4):608-16. doi: 10.1208/s12248-010-9224-y. Epub 2010 Jul 28.

10.

Common variants conferring risk of schizophrenia.

Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Børglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Böttcher Y, Olesen J, Breuer R, Möller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Réthelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA; Genetic Risk and Outcome in Psychosis (GROUP), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA.

Nature. 2009 Aug 6;460(7256):744-7. doi: 10.1038/nature08186. Epub 2009 Jul 1.

11.

Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Brown JS Jr.

Schizophr Bull. 2009 Jan;35(1):256-78. doi: 10.1093/schbul/sbm147. Epub 2008 Jan 31. Review.

Items per page

Supplemental Content

Write to the Help Desk